News

GMS’s ambitions for the next 10 years

GMS’s ambitions for the next 10 years

Genomic Medicine Sweden (GMS) highlights vital aspects for the successful introduction of precision medicine into Swedish healthcare in its Strategy Plan 2021–2030. In Strategy Plan 2021–2030, GMS presents its ambitions for the introduction of precision medicine into...
GMS’s ambitions for the next 10 years

Bettina Lundgren new member of GMS Scientific Advisory Board

Bettina Lundgren, CEO of the Danish National Genome Center, has recently joined the GMS Scientific Advisory Board. “We welcome Bettina Lundgren to our Scientific Advisory Board and look forward to sharing experiences between the Swedish and Danish initiatives”, said...
GMS’s ambitions for the next 10 years

Leading experts join the GMS Scientific Advisory Board

The national board of Genomic Medicine Sweden has appointed Professor Dame Sue Hill, Professor Albrecht Stenzinger, Professor Dag Undlien, Jaana Sinipuro and Professor Peter Løngreen as members of the GMS Scientific Advisory Board. The newly appointed members will...